318 related articles for article (PubMed ID: 38175721)
1. Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy.
Sun M; Shi G; Zhang X; Kan C; Xie S; Peng W; Liu W; Wang P; Zhang R
Aging (Albany NY); 2024 Jan; 16(1):964-982. PubMed ID: 38175721
[TBL] [Abstract][Full Text] [Related]
2.
Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
[TBL] [Abstract][Full Text] [Related]
3. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
Narita I; Gejyo F
Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
[TBL] [Abstract][Full Text] [Related]
5. Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.
Nishie T; Miyaishi O; Azuma H; Kameyama A; Naruse C; Hashimoto N; Yokoyama H; Narimatsu H; Wada T; Asano M
Am J Pathol; 2007 Feb; 170(2):447-56. PubMed ID: 17255313
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
Tanaka M; Seki G; Someya T; Nagata M; Fujita T
Clin Dev Immunol; 2011; 2011():470803. PubMed ID: 21318178
[TBL] [Abstract][Full Text] [Related]
7. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
9. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation in IgA nephropathy (IgAN).
Coppo R; Amore A
Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and Production of Aberrantly
Person T; King RG; Rizk DV; Novak J; Green TJ; Reily C
J Interferon Cytokine Res; 2022 Jul; 42(7):301-315. PubMed ID: 35793525
[TBL] [Abstract][Full Text] [Related]
12. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
Barratt J; Smith AC; Feehally J
Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in IgA nephropathy.
Coppo R; Camilla R; Amore A; Peruzzi L
Nephron Clin Pract; 2010; 116(3):c196-8, discussion c199. PubMed ID: 20606479
[TBL] [Abstract][Full Text] [Related]
14. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
Allen AC
J Nephrol; 1999; 12(2):76-84. PubMed ID: 10378662
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of IgA nephropathy.
Feehally J; Allen AC
Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
17. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
18. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
Kolka R; Valdimarsson H; Bodvarsson M; Hardarson S; Jonsson T
APMIS; 2013 Sep; 121(9):890-7. PubMed ID: 23398317
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
20. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
